Intrexon Corp. (NYSE:XON) shares shot up 8.3% during trading on Monday . The company traded as high as $27.66 and last traded at $27.43, with a volume of 1,377,559 shares traded. The stock had previously closed at $25.33.

A number of brokerages recently commented on XON. Stifel Nicolaus restated a “buy” rating and set a $57.00 price objective on shares of Intrexon Corp. in a research note on Wednesday, April 13th. Griffin Securities restated a “buy” rating and set a $65.00 price objective on shares of Intrexon Corp. in a research note on Tuesday, June 7th. Zacks Investment Research raised Intrexon Corp. from a “hold” rating to a “strong-buy” rating and set a $32.00 price target for the company in a research note on Tuesday, May 3rd. JMP Securities started coverage on Intrexon Corp. in a research note on Tuesday, May 3rd. They issued an “outperform” rating and a $42.00 price target for the company. Finally, Wunderlich reissued a “buy” rating and issued a $50.00 price target on shares of Intrexon Corp. in a research note on Thursday, July 7th. One equities research analyst has rated the stock with a sell rating, three have given a hold rating and seven have assigned a buy rating to the company. The company presently has an average rating of “Buy” and an average target price of $47.70.

The stock’s market capitalization is $3.24 billion. The firm’s 50 day moving average is $24.97 and its 200 day moving average is $29.58.

Intrexon Corp. (NYSE:XON) last posted its earnings results on Tuesday, May 10th. The company reported ($0.55) EPS for the quarter, missing the Thomson Reuters’ consensus estimate of ($0.20) by $0.35. During the same period in the previous year, the business earned $0.25 EPS. The company earned $43.40 million during the quarter, compared to analyst estimates of $46.26 million. Intrexon Corp.’s revenue for the quarter was up 28.4% compared to the same quarter last year. Equities research analysts forecast that Intrexon Corp. will post ($1.32) EPS for the current year.

In related news, CEO Randal J. Kirk bought 41,830 shares of the business’s stock in a transaction that occurred on Friday, May 13th. The stock was acquired at an average price of $23.92 per share, for a total transaction of $1,000,573.60. The purchase was disclosed in a document filed with the SEC, which is available through the SEC website.

Several institutional investors recently bought and sold shares of the company. Dimensional Fund Advisors LP increased its position in Intrexon Corp. by 3.5% in the fourth quarter. Dimensional Fund Advisors LP now owns 141,851 shares of the company’s stock valued at $4,278,000 after buying an additional 4,854 shares during the period. Trexquant Investment LP acquired a new stake in Intrexon Corp. during the fourth quarter worth $2,590,000. Cambridge Investment Research Advisors Inc. boosted its stake in Intrexon Corp. by 261.8% in the fourth quarter. Cambridge Investment Research Advisors Inc. now owns 81,072 shares of the company’s stock worth $2,444,000 after buying an additional 58,667 shares in the last quarter. Wells Fargo & Company MN boosted its stake in Intrexon Corp. by 44.8% in the fourth quarter. Wells Fargo & Company MN now owns 274,040 shares of the company’s stock worth $8,262,000 after buying an additional 84,759 shares in the last quarter. Finally, Bank of Montreal Can boosted its stake in Intrexon Corp. by 16.8% in the fourth quarter. Bank of Montreal Can now owns 40,010 shares of the company’s stock worth $1,207,000 after buying an additional 5,742 shares in the last quarter.

Intrexon Corporation (Intrexon) forms collaborations to create biologically based products and processes using synthetic biology. The Company designs, builds and regulates gene programs, which are deoxyribonucleic acid (DNA) sequences that consist of genetic components. The Company’s synthetic biology capabilities include the ability to control the amount, location and modification of biological molecules to control the function and output of living cells and optimize for desired results at an industrial scale.

Get Analysts' Upgrades and Downgrades Daily - Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.